Fazisiran Injection

Drug identity checked against registry records

Also recorded as ARO-AAT Injection; TAK-999 Injection

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Safety, Tolerability and Pharmacodynamic Effect of Fazirsiran (TAK-999, ARO-AAT)NCT03945292Arrowhead PharmaceuticalsPhase 2Completed2021-11-08Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.